ZINZINO AB (PUBL): PRELIMINARY SALES REPORT MAY 2019
Good sales growth during May; Zinzino based revenue increased 21% and the total group revenue with a total of 10% compared with the previous year.
The revenue for Zinzino's sales markets increased by 21% to SEK 58.6 (48.3) million due to strong growth foremost in Central Europe. Faun Pharma's external sales decreased by 58% and amounted to SEK 3.3 (7.8) million due to high level of internal production during the month. Overall. the Group increased revenues by 10 % to SEK 61.9 (56.1) million compared with the previous year.
Accumulated income January - May increased by 21% to SEK 287.5 (238.5) million compared with the previous year.
Revenues distributed as follows:
|Regions, SEK million||19 May||18 May||Change||YTD 2019||YTD 2018||Change|
|Europe Other Markets||20.2||6.6||208%||80.9||26.0||211%|
The sales figures are prepared according to IFRS. Adjustment for IFRS 15, income from customers has affected comparative figures.
For more information please contact:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700
Pictures for free publication:
Marcus Tollbom +46 (0) 70-190 03 12
Erik Penser Bank Aktiebolag: +46 (0)8 463 83 00 Email: firstname.lastname@example.org
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 16:00 the 12th of June, 2019.